Get started
Author

Manushak Avagyan

Observed names: Avagyan, Manushak, M. AVAGYAN, M. Avagyan, M., Avagyan, Manush Avagyan
ORCID: 0000-0003-2207-3107
Observed ORCID: 0000-0003-2207-3107
OpenAlex ID: A5047404175
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas
2025 · Breelyn A. Wilky, Gary K. Schwartz, et al. · Journal of Clinical Oncology · 23
PDF
Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
2023 · Nils-Petter Rudqvist, Manushak Avagyan, et al. · OncoImmunology · 8
PDF
Risk factors of childhood cancer in Armenia: a case-control study
2023 · Manushak Avagyan, Anahit Demirchyan, et al. · BMC Cancer · 8
PDF
8P Botensilimab plus balstilimab in an expanded cohort of 123 patients with metastatic microsatellite-stable colorectal cancer and no active liver metastases
2025 · B.L. Schlechter, M. Fakih, et al. · Annals of Oncology · 3
PDF
Trends in pediatric CNS tumors in Armenia: a multicenter retrospective study
2023 · Julieta Hoveyan, Eduard Asatryan, et al. · Child s Nervous System · 3
Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square · 3
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma
2026 · Anthony B. El-Khoueiry, Christopher H. Lieu, et al. · Liver Cancer · 1
PDF
1726MO Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study
2024 · B.A. Wilky, J.C. Trent, et al. · Annals of Oncology · 1
Secondary Malignancy In Giant Cell Tumor Of The Skull Base After Denosumab Treatment: Case Report
2023 · M. AVAGYAN, L. KAGER, et al. · THE NEW ARMENIAN MEDICAL JOURNAL · 1
PDF
Etmr-07. Etantr: a Rare Tumor in a Resource-limited Setting
2020 · Julieta Hoveyan, Manushak Avagyan, et al. · Neuro-Oncology · 1
Linc-14. Treatment of Pediatric Cns Tumors in Armenia. 10 Years of Experience in a 29 Years Old Resource-limited Setting
2020 · Martin Harutyunyan, Lilit Sargsyan, et al. · Neuro-Oncology · 1
PDF
Extended Follow-up of Botensilimab plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer without Active Liver Metastases
2026 · Benjamin L. Schlechter, Marwan G. Fakih, et al. · Clinical Cancer Research
PDF
Supplementary Material for: A phase 1b study of botensilimab and balstilimab in treatment-refractory hepatocellular carcinoma
2026 · karger, figshare admin, A.B., El-Khoueiry, et al. · Figshare
Abstract LB365: Results from a phase 1 study of botensilimab and balstilimab in treatment refractory hepatocellular carcinoma
2025 · Anthony B. El-Khoueiry, Ghassan K. Abou-Alfa, et al. · Cancer Research
MM-322 Impact of Extramedullary Disease on Outcomes in Newly Diagnosed Multiple Myeloma Patients: A Retrospective Study from a Single Center
2023 · Nerses Ghahramanyan, Manushak Avagyan, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-322 Impact of Extramedullary Disease on Outcomes in Newly Diagnosed Multiple Myeloma Patients: A Retrospective Study from a Single Center
2023 · Nerses Ghahramanyan, Manushak Avagyan, et al. · Clinical Lymphoma Myeloma & Leukemia
Epidemiology, treatment, and outcomes of children and young adults with central nervous system tumors in Armenia
2023 · Julieta Hoveyan, Eduard Asatryan, et al.
Continuing cyclin-dependent kinase 4/6 inhibition in metastatic breast cancer patients previously treated with another cyclin-dependant kinase 4/6 inhibitor: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square
PDF
Continuing cyclin dependent kinase 4/6 inhibition with abemaciclib in metastatic breast cancer patients previously treated with palbociclib or ribociclib: a protocol for systematic review and meta-analysis
2022 · Alicia de Luna Aguilar, Javier David Benitez Fuentes, et al. · Research Square
Rare-33. Giant Cell Tumor of the Skull Base With a History of a Successful Response to Denosumab and Later Developing a Second Tumor
2020 · Manushak Avagyan, Gevorg Tamamyan, et al. · Neuro-Oncology
Childhood Hodgkin Lymphoma in Armenia: 10 Years of Experience in a Resource-Limited Setting
2019 · Manush Avagyan, Ruzanna Papyan, et al. · Clinical Lymphoma Myeloma & Leukemia
The Effectiveness of Chemoprophylaxis Introduction in Acute Leukemia Management in Armenia
2018 · Karen Meliksetyan, Armen Sanosyan, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 24
Citation count: 53
H-index: 3
I10-index: 1
Year
Topic
Type